These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26568790)

  • 1. Long-term oncologic outcomes of postoperative adjuvant versus salvage radiotherapy in prostate cancer: Systemic review and meta-analysis of 5-year and 10-year follow-up data.
    Ku JY; Lee CH; Ha HK
    Korean J Urol; 2015 Nov; 56(11):735-41. PubMed ID: 26568790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognosis benefits of adjuvant versus salvage radiotherapy for patients after radical prostatectomy with adverse pathological features: a systematic review and meta-analysis.
    Tao R; Dai J; Bai Y; Yang J; Sun G; Zhang X; Zhao J; Zeng H; Shen P
    Radiat Oncol; 2019 Nov; 14(1):197. PubMed ID: 31706339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant versus early salvage radiotherapy: outcome of patients with prostate cancer treated with postoperative radiotherapy after radical prostatectomy.
    Vogel MME; Kessel KA; Schiller K; Devecka M; Gschwend JE; Weichert W; Wilkens JJ; Combs SE
    Radiat Oncol; 2019 Nov; 14(1):198. PubMed ID: 31711524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database.
    Hervás A; Gómez-Caamaño A; Casaña M; Gómez-Iturriaga A; Pastor J; Jove J; Mengual JL; Gónzalez-San Segundo C; Muñoz J
    Clin Transl Oncol; 2018 Feb; 20(2):193-200. PubMed ID: 28667448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative adjuvant and very early salvage radiotherapy after prostatectomy in high-risk prostate cancer patients can improve specific and overall survival.
    Casas F; Valduvieco I; Oses G; Izquierdo L; Archila I; Costa M; Cortes KS; Barreto T; Ferrer F
    Clin Transl Oncol; 2019 Mar; 21(3):355-362. PubMed ID: 30128953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer.
    Trabulsi EJ; Valicenti RK; Hanlon AL; Pisansky TM; Sandler HM; Kuban DA; Catton CN; Michalski JM; Zelefsky MJ; Kupelian PA; Lin DW; Anscher MS; Slawin KM; Roehrborn CG; Forman JD; Liauw SL; Kestin LL; DeWeese TL; Scardino PT; Stephenson AJ; Pollack A
    Urology; 2008 Dec; 72(6):1298-302; discussion 1302-4. PubMed ID: 18672274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data.
    Vale CL; Fisher D; Kneebone A; Parker C; Pearse M; Richaud P; Sargos P; Sydes MR; Brawley C; Brihoum M; Brown C; Chabaud S; Cook A; Forcat S; Fraser-Browne C; Latorzeff I; Parmar MKB; Tierney JF;
    Lancet; 2020 Oct; 396(10260):1422-1431. PubMed ID: 33002431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant and salvage radiotherapy after prostatectomy: a systematic review and meta-analysis.
    Chen C; Lin T; Zhou Y; Li D; Xu K; Li Z; Fan X; Zhong G; He W; Chen X; He X; Huang J
    PLoS One; 2014; 9(8):e104918. PubMed ID: 25121769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series.
    Fossati N; Karnes RJ; Boorjian SA; Moschini M; Morlacco A; Bossi A; Seisen T; Cozzarini C; Fiorino C; Noris Chiorda B; Gandaglia G; Dell'Oglio P; Joniau S; Tosco L; Shariat S; Goldner G; Hinkelbein W; Bartkowiak D; Haustermans K; Tombal B; Montorsi F; Van Poppel H; Wiegel T; Briganti A
    Eur Urol; 2017 Jun; 71(6):886-893. PubMed ID: 27484843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy.
    Tilki D; Preisser F; Tennstedt P; Tober P; Mandel P; Schlomm T; Steuber T; Huland H; Schwarz R; Petersen C; Graefen M; Ahyai S
    BJU Int; 2017 May; 119(5):717-723. PubMed ID: 27743493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features.
    Hwang WL; Tendulkar RD; Niemierko A; Agrawal S; Stephans KL; Spratt DE; Hearn JW; Koontz BF; Lee WR; Michalski JM; Pisansky TM; Liauw SL; Abramowitz MC; Pollack A; Moghanaki D; Anscher MS; Den RB; Zietman AL; Stephenson AJ; Efstathiou JA
    JAMA Oncol; 2018 May; 4(5):e175230. PubMed ID: 29372236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: comparative analysis of long-term outcomes.
    Mishra MV; Scher ED; Andrel J; Margules AC; Hegarty SE; Trabulsi EJ; Hyslop T; Den RB; Lallas CD; Gomella LG; Dicker AP; Showalter TN
    Am J Clin Oncol; 2015 Feb; 38(1):55-60. PubMed ID: 24051934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer.
    Taylor N; Kelly JF; Kuban DA; Babaian RJ; Pisters LL; Pollack A
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):755-63. PubMed ID: 12788182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen decline during salvage radiation therapy following prostatectomy is associated with reduced biochemical failure.
    Kabarriti R; Ohri N; Hannan R; Tishbi N; Baliga S; McGovern KP; Mourad WF; Ghavamian R; Kalnicki S; Guha C; Garg MK
    Pract Radiat Oncol; 2014; 4(6):409-14. PubMed ID: 25407863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing biochemical recurrence in patients who have received salvage radiotherapy after radical prostatectomy: a systematic review and meta-analysis.
    Jia ZW; Chang K; Dai B; Kong YY; Wang Y; Qu YY; Zhu YP; Ye DW
    Asian J Androl; 2017; 19(4):493-499. PubMed ID: 27241314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjuvant vs. salvage radiotherapy after radical prostatectomy].
    Bartkowiak D; Schrader AJ; Wiegel T
    Aktuelle Urol; 2015 Jan; 46(1):52-8. PubMed ID: 25658231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy after radical prostatectomy: immediate or early delayed?
    Bottke D; Bartkowiak D; Schrader M; Wiegel T
    Strahlenther Onkol; 2012 Dec; 188(12):1096-101. PubMed ID: 23128897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in adjuvant and early salvage radiotherapy after robot-assisted radical prostatectomy for prostate cancer: a population-based cohort study.
    Draulans C; Van Damme N; Isebaert S; Everaerts W; Silversmit G; Joniau S; De Meerleer G; Van Eycken E; Haustermans K;
    Acta Oncol; 2020 Aug; 59(8):904-910. PubMed ID: 32723224
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer-specific Mortality: Competition Between Age and Time to Biochemical Failure.
    Jackson WC; Suresh K; Tumati V; Dess RT; Soni PD; Zhao SG; Zumsteg ZS; Hannan R; Hollenbeck BK; George A; Kaffenberger SD; Salami SS; Hearn JWD; Morgan TM; Mehra R; Schipper M; Feng FY; Desai NB; Spratt DE
    Eur Urol Oncol; 2018 Sep; 1(4):276-282. PubMed ID: 31100248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant versus early Salvage radiation therapy for prostate cancer with adverse pathological features on radical prostatectomy-Do we finally have an answer?
    Jain S; Mallick I; Tamhankar AS; Gautam G
    Indian J Cancer; 2022; 59(2):170-177. PubMed ID: 35946183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.